首页> 外文OA文献 >Regulation of visceral adipose tissue-derived serine protease inhibitor by nutritional status, metformin, gender and pituitary factors in rat white adipose tissue
【2h】

Regulation of visceral adipose tissue-derived serine protease inhibitor by nutritional status, metformin, gender and pituitary factors in rat white adipose tissue

机译:营养状态,二甲双胍,性别和垂体因子在大鼠白色脂肪组织中对内脏脂肪组织丝氨酸蛋白酶抑制剂的调节

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Visceral adipose tissue-derived serine protease inhibitor (vaspin) is a recently discovered adipocytokine mainly secreted from visceral adipose tissue, which plays a main role in insulin sensitivity. In this study, we have investigated the regulation of vaspin gene expression in rat white adipose tissue (WAT) in different physiological (nutritional status, pregnancy, age and gender) and pathophysiological (gonadectomy, thyroid status and growth hormone deficiency) settings known to be associated with energy homeostasis and alterations in insulin sensitivity. We have determined vaspin gene expression by real-time PCR. Vaspin was decreased after fasting and its levels were partially recovered after leptin treatment. Chronic treatment with metformin increased vaspin gene expression. Vaspin mRNA expression reached the highest peak at 45 days in both sexes after birth and its expression was higher in females than males, but its levels did not change throughout pregnancy. Finally, decreased levels of growth hormone and thyroid hormones suppressed vaspin expression. These findings suggest that WAT vaspin mRNA expression is regulated by nutritional status, and leptin seems to be the nutrient signal responsible for those changes. Vaspin is influenced by age and gender, and its expression is increased after treatment with insulin sensitizers. Finally, alterations in pituitary functions modify vaspin levels. Understanding the molecular mechanisms regulating vaspin will provide new insights into the pathogenesis of the metabolic syndrome.
机译:内脏脂肪组织衍生的丝氨酸蛋白酶抑制剂(vaspin)是最近发现的主要由内脏脂肪组织分泌的脂肪细胞因子,在胰岛素敏感性中起主要作用。在这项研究中,我们研究了已知在不同生理状态(营养状况,妊娠,年龄和性别)和病理生理状态(性腺切除术,甲状腺状况和生长激素缺乏症)的大鼠白色脂肪组织(WAT)中vaspin基因表达的调控。与能量稳态和胰岛素敏感性改变有关。我们已经通过实时PCR确定了vaspin基因的表达。禁食后Vaspin降低,瘦素治疗后其水平部分恢复。长期使用二甲双胍治疗可增加vaspin基因表达。 Vaspin mRNA的表达在出生后45天达到最高峰,雌性比雄性高,但在整个怀孕过程中其水平均未改变。最后,生长激素和甲状腺激素水平降低抑制了vaspin表达。这些发现表明,WAT vaspin mRNA表达受营养状况的调节,而瘦素似乎是造成这些变化的营养信号。 Vaspin受年龄和性别的影响,在用胰岛素敏化剂治疗后,Vaspin的表达增加。最后,垂体功能的改变会改变vaspin水平。了解调节瓦斯平的分子机制将为代谢综合征的发病机理提供新的见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号